These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6370148)

  • 21. Phagocyte function in reactive arthritis.
    Leirisalo-Repo M; Repo H
    Scand J Rheumatol Suppl; 1988; 76():73-7. PubMed ID: 3075090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal permeability in patients with yersinia triggered reactive arthritis.
    Lahesmaa-Rantala R; Magnusson KE; Granfors K; Leino R; Sundqvist T; Toivanen A
    Ann Rheum Dis; 1991 Feb; 50(2):91-4. PubMed ID: 1998397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxygen radical production and trapping in subjects with previous Yersinia infection.
    Ristola M; Metsä-Ketelä T; Leirisalo-Repo M; Repo H
    Inflammation; 1992 Jun; 16(3):273-83. PubMed ID: 1323531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients.
    Biasi D; Carletto A; Caramaschi P; Bellavite P; Andrioli G; Caraffi M; Pacor ML; Bambara LM
    Clin Exp Rheumatol; 1995; 13(5):623-7. PubMed ID: 8575141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandins in the guinea pig cochlea.
    Sauer C; Ettl K; Firbas W; Sinzinger H
    Prog Clin Biol Res; 1987; 242():131-7. PubMed ID: 3478731
    [No Abstract]   [Full Text] [Related]  

  • 26. Yersinia arthritis: a clinical, immunological, and family study of 2 cases.
    Sheldon PJ; Mair NS; Fox E
    Ann Rheum Dis; 1982 Apr; 41(2):153-8. PubMed ID: 6978685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yersinia antibodies in inflammatory joint diseases.
    Granfors K; Isomäki H; von Essen R; Maatela J; Kalliomäki JL; Toivanen A
    Clin Exp Rheumatol; 1983; 1(3):215-8. PubMed ID: 6335856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.
    Leino R; Vuento R; Koskimies S; Viander M; Toivanen A
    Ann Rheum Dis; 1983 Apr; 42(2):176-81. PubMed ID: 6342552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HLA-antigens and some pathogenetic aspects of reactive arthritis].
    Sidel'nikova SM; Kut'ina RM; Zotikov EA
    Ter Arkh; 1998; 70(5):20-4. PubMed ID: 9644736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasis, neutrophil leukocytes, and HLA-B27.
    Cox NH
    J Am Acad Dermatol; 1987 Aug; 17(2 Pt 1):312-3. PubMed ID: 3497957
    [No Abstract]   [Full Text] [Related]  

  • 31. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.
    Koivuranta-Vaara P; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1987 Apr; 46(4):307-13. PubMed ID: 3592787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of hybridization between Yersinia enterocolitica and HLA-B27 DNA.
    Viitanen AM; Lahesmaa-Rantala R; Weiss E; Toivanen A
    J Rheumatol; 1988 Jul; 15(7):1123-5. PubMed ID: 3262758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Articular manifestations of Yersinia infections. Apropos of 4 personal cases. Review of the literature].
    Magub M; Sany J; Le Peu G; Bertrand A; Blanc F; Bertrand L
    Rev Rhum Mal Osteoartic; 1983 Feb; 50(2):115-24. PubMed ID: 6344185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria.
    Kono DH; Ogasawara M; Effros RB; Park MS; Waldord RL; Yu DT
    Clin Exp Immunol; 1985 Sep; 61(3):503-8. PubMed ID: 3878239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive arthritis.
    Aho K; Leirisalo-Repo M; Repo H
    Clin Rheum Dis; 1985 Apr; 11(1):25-40. PubMed ID: 3888504
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of H-2 genes on expression of HLA-B27 and Yersinia-induced arthritis.
    Nickerson CL; Hogen KL; Luthra HS; David CS
    Scand J Rheumatol Suppl; 1990; 87():85-90; discussion 90. PubMed ID: 2259892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tetrapeptide shared by Yersinia outer membrane protein Yop1 and HLA-B27. Antibody response in patients with Yersinia-triggered reactive arthritis.
    Lahesmaa R; Skurnik M; Granfors K; Möttönen T; Saario R; Toivanen A; Toivanen P
    Scand J Rheumatol Suppl; 1990; 87():70-1. PubMed ID: 1701921
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pathogenesis of infectious arthritis].
    Piaĭ LT
    Revmatologiia (Mosk); 1983; (4):3-5. PubMed ID: 6199826
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of prostaglandins E1, E2, F2 alpha, I2 and thromboxane in salmonella-associated arthritis in rats.
    Karmali RA; Davies J; Volkman A
    Prostaglandins Leukot Med; 1982 May; 8(5):437-46. PubMed ID: 7048334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired cell-mediated immunity among HLA-B27 related rheumatoid variants responding to Yersinia antigen.
    Goebel KM; Goebel FD; Baier R
    J Clin Lab Immunol; 1982 Jun; 8(2):75-81. PubMed ID: 6213777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.